The cooperation agreement signed between the group and Shenzhen
Source: Internet
Author: User
Consistent pharmaceutical Industry (000028) bulletin, the company's actual control of China Pharmaceutical Group Corporation September 8 signed a strategic cooperation framework agreement with the Shenzhen government. According to the agreement, the Chinese Medicine group will establish the South China Biomedical Research and Development Center in Shenzhen and South China Bio-pharmaceutical Production Alliance, together to build Shenzhen bio-pharmaceutical industry development incubator. Shenzhen supports the construction of the pharmaceutical supply guarantee system covering Shenzhen city. Priority is given to the use of consistent medicine as the major enterprise of centralized distribution of drugs (including essential drugs) and the main fixed-point unit of local Medicine reserve. The two sides carry out strategic cooperation in pharmaceutical industry, such as biopharmaceutical, chemical pharmacy, chemical reagent and diagnostic reagent, modernization of Chinese Medicine, international industrial platform of medical devices, and promote the merger and reorganization of Shenzhen pharmaceutical enterprises.
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.
